CClinicalTrials.gg
CompletedNCT02593448Updated Nov 1, 2015

Influence of Cardiopulmonary Bypass, and Sevoflurane or Propofol Anesthesia, on Tissue Oxygen Saturation.

A Phase 4 interventional study of NIRS during VOT and General anaesthesia with propofol use in NIR Spectroscopy, sponsored by Medical University of Gdansk. Completed at 1 site in Poland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-11-01.

Sponsored by Medical University of Gdansk · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the present study is to assess, by near infrared spectroscopy with INVOS oximeter during vascular occlusion test (VOT), the influence of cardiopulmonary bypass on tissue saturation in thenar muscle.

The secondary aim is to compare the effects of propofol and sevoflurane anaesthesia on tissue saturation.

It is a prospective, randomized, open-label study. Sixty cardiac surgery patients will receive either propofol or sevoflurane anaesthesia. Three-minute VOT will be performed at the following time points: 30 minutes after anaesthesia induction, directly after sternotomy, 20 and 40 minutes after aortic cross-clamping, 20 minutes after aortic cross-clamp removal, and 45 minutes after weaning of cardiopulmonary bypass (CPB).

Group and time effects on tissue saturation will be analysed with ANOVA and post hoc Tukey's test.

Read the detailed description

Near-infrared spectroscopy (NIRS) is a modern technique for cardiac surgical patient monitoring. The NIRS method is based on Lambert-Beer's law, which defines the relationship between the concentration of a substance and reduction of the intensity of electro-magnetic radiation. This reduction results from photon absorption by chromatophores, including haemoglobin, myoglobin and cytochrome P1. Absorption at the given wave-length depends on the degree of chromatophore oxygenation, and hence allows for its assessment. NIRS is currently commonly used for the assessment of brain oximetry in thoracic aorta surgery and, increasingly often, in open-heart surgery. Algorithms for sustaining adequate brain saturation were reported to decrease the incidence of neurological complications following cardiac surgery. In recent years, NIRS was proposed as a tool for the assessment of muscle saturation under short-term ischaemia and reperfusion, referred to as the vascular occlusion test (VOT). VOT is a provocative test in which tissue saturation (StO2) is measured at a peripheral site, such as the thenar eminence, while blood flow is transiently occluded with sphygmomanometer. After reaching a predefined ischaemia time or minimal StO2 threshold, the sphygmomanometer tourniquet is rapidly deflated and blood flow in the muscle is restored. Tissue saturation measurement during VOT can identify early disturbances in tissue metabolism and perfusion. The speed of the decrease in tissue saturation on ischaemia was proposed to reflect the local metabolic rate, while the lowest tissue saturation was proposed to reflect the extent of ischaemia. The speed of tissue saturation recovery on reperfusion in shock patients was proposed as a measure of microvascular capacity to increase blood flow after transient ischaemia. The results of recent studies indicated that the speed of the fall of muscle saturation during VOT is reduced in septic shock, while a decreased speed of saturation recovery on reperfusion is related to disturbed microcirculation, for example in hypovolemic shock. An understanding of anaesthetics and of the influence of cardiac surgical procedures on tissue saturation profile during VOT is essential for the future use of this tool for the assessment of the condition of patients during CPB cardiac surgery.

02

Conditions studied

  • NIR Spectroscopy

Keywords

  • Cardiopulmonary Bypass
  • Anoxia
03

In context

Lead sponsor

Medical University of Gdansk is the lead sponsor of 130 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • adult
  • scheduled for elective, open-heart cardiac surgical operation with use of cardiopulmonary bypass.
  • signed written consent

Exclusion criteria

Exclusion Criteria:

  • surgeon's intention to use the radial artery for arterial bypass
  • symptoms of peripheral atherosclerosis
  • paresis of a limb
  • autoimmune disease
  • other factors that could potentially affect blood flow in the upper extremities
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (actual)

Study arms

  • Active comparator
    Propofol

    General anaesthesia with Propofol use. Maintenance of anaesthesia in group P will be accomplished using continuous intravenous infusion of propofol 2-4 mg kg/h. Propofol infusion rate will be adjusted according to patient's haemodynamic parameters and the level of anaesthesia, as assessed with Bispectral Index (BIS), with a target range of 40-60. Intervention: NIRS during VOT on several timepoints.

    Procedure: NIRS during VOT · Procedure: General anaesthesia with propofol use

  • Experimental
    Sevoflurane

    General anaesthesia with sevoflurane use. Sevoflurane concentration in exhaled gas will be adjusted according to patient's haemodynamic parameters and the level of anaesthesia, as assessed with BIS, with a target range of 40-60. Intervention: NIRS during VOT on several timepoints.

    Procedure: NIRS during VOT · Procedure: General anaesthesia with sevoflurane use

Interventions

  • ProcedureNIRS during VOT

    Near infrared spectroscopy with INVOS oximeter during vascular occlusion test (VOT) on following timepoints: 1. 30 minutes after anaesthesia induction, 2. directly after the sternotomy, 3. during CPB - 20 minutes after aortic cross-clamping , 4. 40 minutes after aortic cross-clamping, 5. 20 minutes after the release of the aortic cross-clamp, 6. 45 minutes after weaning of CPB.

  • ProcedureGeneral anaesthesia with propofol use

    Premedication: lorazepam 50 μg kg-1, omeprazole 40 mg, and metoprolol 12.5 mg one hour before transport to the operating theatre. Anaesthesia induction: 0.2 mg fentanyl, 0.3 mg/kg, etomidate, and vecuronium bromide 0.1 mg/kg for muscle relaxation, followed by a continuous infusion at the rate of 0.05 mg/kg/h until the sternum closure. Intraoperative analgesia: fentanyl in fractions, up to the total dose of 20-30 μg/kg. Maintenance of anaesthesia in 'Propofol' group will be accomplished using continuous intravenous infusion of propofol 2-4 mg kg/h. Propofol infusion rate will be adjusted according to patient's haemodynamic parameters and the level of anaesthesia, as assessed with Bispectral Index (BIS), with a target range of 40-60.

    Also known as: Propofol Total Intravenous Anesthesia (TIVA)

  • ProcedureGeneral anaesthesia with sevoflurane use

    Premedication: lorazepam 50 μg kg-1, omeprazole 40 mg, and metoprolol 12.5 mg one hour before transport to the operating theatre. Anaesthesia induction: 0.2 mg fentanyl, 0.3 mg/kg, etomidate, and vecuronium bromide 0.1 mg/kg for muscle relaxation, followed by a continuous infusion at the rate of 0.05 mg/kg/h until the sternum closure. Intraoperative analgesia: fentanyl in fractions, up to the total dose of 20-30 μg/kg. Sevoflurane concentration in exhaled gas will be adjusted according to patient's haemodynamic parameters and the level of anaesthesia, as assessed with BIS, with a target range of 40-60.

    Also known as: Sevoflurane anaesthesia

06

What researchers measure

Primary outcomes

  1. Changes in thenar muscle saturation

    Thenar muscle tissue saturation was continuously monitored using an INVOS NIRS monitor (INVOS-YM 5100C Cerebral Somatic Oximeter, Covidien, Mansfield, USA). Thenar muscle saturation was measured during VOT 30 minutes after anaesthesia induction, which will be regarded baseline value. At five another timepoints VOT was performed and changes in thenar muscle saturation were measured: 1. directly after the sternotomy, 2. during CPB - 20 minutes after aortic cross-clamping, 3. 40 minutes after aortic cross-clamping, 4. 20 minutes after the release of the aortic cross-clamp, 5. 45 minutes after weaning of CPB.

    Time frame: During VOT performed at 6 timepoints

07

Study locations

1 site
  • Medical University of Gdańsk, Department of Cardiac Anesthesiology
    Gdańsk, Pomorskie PL 80-211, Poland
08

References and documents

Publications

  • Biedrzycka A, Kowalik M, Pawlaczyk R, Jagielak D, Swietlik D, Szymanowicz W, Lango R. Aortic cross-clamping phase of cardiopulmonary bypass is related to decreased microvascular reactivity after short-term ischaemia of the thenar muscle both under intravenous and volatile anaesthesia: a randomized trial. Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):770-778. doi: 10.1093/icvts/ivw232. Epub 2016 Jul 8. PubMed 27401083 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02593448
Lead sponsor
Medical University of Gdansk
Responsible party
Maciej M. Kowalik (Dr hab. med. Romuald Lango, Medical University of Gdansk) — Principal investigator
First posted
Nov 1, 2015
Start date
Mar 2012
Primary completion
Apr 2013
Completion
Aug 2014
Last update
Nov 1, 2015

Study contacts

Alexandra Biedrzycka, M.D., Ph.D.
principal investigator · Medical University of Gdańsk, Department of Cardiac Anesthesiology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion